Massachusetts S2520 regulates prescription drug pricing and establishes a cost assistance program.

Massachusetts S2520 amends state law to regulate prescription drug pricing, focusing on drugs with significant price increases. It defines a "significant price increase" for generic drugs priced at $100 or more per wholesale acquisition cost unit that increases by 100% or more within 12 months. The bill also mandates early notice to the health policy commission for price increases of brand-name drugs by more than 15% per unit over 12 months. The commission reviews eligible drugs, sets upper payment limits, and consults with stakeholders to mitigate costs.

Massachusetts S2520 regulates prescription drug pricing and establishes a cost assistance program.

Massachusetts S2520 amends state law to regulate prescription drug pricing, focusing on drugs with significant price increases. It defines a "significant price increase" for generic drugs priced at $100 or more per wholesale acquisition cost unit that increases by 100% or more within 12 months. The bill also mandates early notice to the health policy commission for price increases of brand-name drugs by more than 15% per unit over 12 months. The commission reviews eligible drugs, sets upper payment limits, and consults with stakeholders to mitigate costs.